TimothyEdwinWilensMD

Addiction, Child & Adolescent Psychiatry, Psychopharmacology

Chief, Division of Child and Adolescent Psychiatry and Co-Director, Center for Addiction Medicine (CAM), Massachusetts General Hospital. Professor of Psychiatry at Harvard Medical School.

Join to view full profile

Dr. Wilens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wilens' full profile

Already have an account?

Office
55 Fruit St
Yaw 6900
Boston, MA 02114
Phone+1 617-643-3481

Fax+1 617-724-3742

Summary

Dr. Timothy Wilens is a psychiatrist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 32 years. He specializes in addiction, child & adolescent psychiatry, and psychopharmacology and is experienced in attention-deficit/hyperactivity disorder, substance abuse, health outcomes research, attention deficit disorder with hyperactivity, and central nervous system stimulants.

Education & Training

Massachusetts General Hospital/McLean HospitalFellowship, Child and Adolescent Psychiatry, 1988 - 1990
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1986 - 1988
Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1985 - 1986
University of Michigan Medical SchoolClass of 1985

Certifications & Licensure

MA State Medical License 1987 - 2025
MI State Medical License Active through 1986
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Awards, Honors, & Recognition

Boston Magazine Castle Connolly, 2008-2022
America's Top Doctors Castle Connolly
Super Doctor SuperDoctors.com

Clinical Trials

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Start of enrollment: 2004 Sep 01
Completed
Phase 4
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD Start of enrollment: 2004 Jan 01
Completed
Phase 4
Study of Medication Patch to Treat Children Ages 6-12 With ADHD Start of enrollment: 2006 Sep 01
Completed
Phase 4
Efficacy and Safety of SPD503 in Combination With Psychostimulants Start of enrollment: 2008 Sep 02
Completed
Phase 3
Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2009 Apr 01
Terminated
Phase 4
An Open Trial of Sustained Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults With ADHD Plus Substance Use Disorders Start of enrollment: 1999 Jan 01
Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD
Withdrawn
Phase 4
Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD) Start of enrollment: 2011 Nov 01
Completed
Phase 2
Omega-3 Supplementation to ADHD Medication in Children Start of enrollment: 2014 Jul 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

148 citations
Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood
Timothy E. Wilens, Thomas J. Spencer
Postgraduate Medicine. 2010-09-01
559 citations
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study.
Joseph Biederman, Michael C. Monuteaux, Eric Mick, Thomas J. Spencer, Timothy E. Wilens
Psychological Medicine. 2006-02-01
237 citations
Psychiatric Comorbidity and Functioning in Clinically Referred Preschool Children and School-Age Youths With ADHD
Timothy E. Wilens, Joseph Biederman, Sarah Brown, Sarah Tanguay, Michael C. Monuteaux
Journal of the American Academy of Child and Adolescent Psychiatry. 2002-03-01

Journal Articles

Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts
Helena Hansen, Elizabeth E Krans, Timothy E Wilens, JAMA Network Open

Lectures

Conduct Disorder and ADHD: Predictors for Substance Abuse
163rd Annual Meeting, New Orleans, Louisiana, USA
Conduct Disorder and ADHD: Predictors for Substance Abuse
American Psychiatric Association, 163rd Annual Meeting, New Orleans, Louisiana, USA

Authored Content

Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in MassachusettsMay 2020

Press Mentions

Tris Pharma’s Clonidine Hydrochloride Available to Treat ADHDOctober 20th, 2024
Adderall Shortage Is so Bad Some Patients Can’t Fill Their PrescriptionsOctober 20th, 2022
Champlain Joins Mass General, Harvard to Enhance Campus Mental HealthApril 7th, 2021
Join now to see all

Grant Support

Etiologies Of Stimulant Misuse In College StudentsNational Institute On Drug Abuse2009–2011
Juvenile Bipolar Disorder And Substance AbuseNational Institute On Drug Abuse2006–2010
Atomoxetine In Adolescents With ADHD And SUDNational Institute On Drug Abuse2004–2008
Substance Abuse In ADHD GirlsNational Institute On Drug Abuse2002–2006
Substance Abuse In Juvenile Bipolar DisorderNational Institute On Drug Abuse2000–2004
Long Term Drug Abuse In ADHDNational Institute On Drug Abuse1999–2002
Drug Abuse &Adhd In Adults &Their High Risk OffspringNational Institute On Drug Abuse1997–2001
Addictive Disorder Risk In Children--PsychopathologyNational Institute Of Mental Health1994–1998